好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Kynurenine pathway profiling in phase 2a trial secondary progressive multiple Sclerosis patients treated with a myeloid directed innate immune modulator MIS416
Multiple Sclerosis
P2 - (-)
356
Authors/Disclosures
Chai Lim
PRESENTER
No disclosure on file
Gill Webster, PhD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file